Avantor (AVTR) Received its Third Buy in a Row

After Wells Fargo and Robert W. Baird gave Avantor (NYSE: AVTR) a Buy rating last month, the company received another Buy, this time from Jefferies. Analyst Brandon Couillard maintained a Buy rating on Avantor yesterday and set a price target of $45.00. The company’s shares closed last Friday at $37.14.

According to TipRanks.com, Couillard is a top 25 analyst with an average return of 26.9% and a 75.0% success rate. Couillard covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, Exact Sciences, and Agilent.

Avantor has an analyst consensus of Strong Buy, with a price target consensus of $47.00, a 26.5% upside from current levels. In a report issued on January 27, Barclays also maintained a Buy rating on the stock with a $41.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $44.37 and a one-year low of $26.14. Currently, Avantor has an average volume of 3.7M.

Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AVTR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Read More on AVTR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed